Closed

National Early Inflammatory Autoimmune Diseases Audit

Healthcare Quality Improvement Partnership Ltd

Value
£7,701,346
Published
1 Oct 2026
Deadline
2 Nov 2026
Procedure
Open procedure
Category
85100000 — Health services
Location
UK, United Kingdom
Notice reference
092791-2026

Requirements summary

Healthcare Quality Improvement Partnership Ltd is procuring a national clinical audit service for early inflammatory autoimmune diseases, initially covering NHS-funded care in England and Wales and publicly funded care in Jersey for three years, with an optional 24-month extension. The core scope continues the existing audit (currently delivered by the BSR), measuring provider performance against NICE QS33 and QS214 and developing a paediatric inflammatory arthritis pathway dataset. Core three-year budget is £778,316 excluding VAT (£933,979.20 including VAT), with an overall ceiling of £6,417,788 excluding VAT including aspirational measures and extension.

Key requirements

  • Deliver a continuous prospective national clinical audit benchmarking provider performance against NICE QS33 and QS214 and other relevant standards
  • Develop and report a minimum viable paediatric inflammatory arthritis pathway dataset aligned with forthcoming GIRFT guidance
  • Provide near real-time interactive results, an annual state of the nation report with organisational survey, and outlier identification
  • Deliver targeted quality improvement support and resources after each annual audit cycle, building on existing networks
  • Engage patients, carers and the public and incorporate validated PROMs
  • Core contract of three years for England, Wales and Jersey, with optional 24-month extension and aspirational measures subject to funding
  • Bids above the core budget limit of £778,316 excluding VAT will be rejected; tender closes 2 November 2026

Similar open notices

National Early Inflammatory Autoimmune Diseases Audit —… | ProposAI